Evgen's Series A - II Round

Evgen raised a round of funding on July 25, 2012.

Evgen Pharma is a clinical stage drug development company focused on cancer and neurological disease. The company is focused in the development of pharmaceuticals that activate the antioxidant respons…

Articles about Evgen's Series A - II Round: